Adial Pharmaceuticals, Inc.
ADIL
$6.45
-$0.20-3.01%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -584.00% | 13.16% | 39.55% | 38.28% | 30.96% |
| Total Depreciation and Amortization | 0.00% | -50.00% | -50.00% | -50.00% | -50.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4,359.50% | -21.72% | -82.70% | -82.31% | -82.64% |
| Change in Net Operating Assets | -147.97% | -67.09% | 20.64% | 3.48% | 489.69% |
| Cash from Operations | -71.73% | 5.25% | 6.20% | 1.03% | -1.49% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -100.00% | -- | -- | -- |
| Cash from Investing | 3,421.33% | -100.00% | -- | -57.14% | -78.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -52.13% | 114.58% | 8.00% | -25.14% | 104.73% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 219.76% | 114.58% | 8.00% | -47.69% | 15.49% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 767.97% | 183.40% | 130.69% | -112.24% | 26.90% |